Spermosens AB Stock

Stocks

SPERM

SE0015346424

End-of-day quote NORDIC GROWTH MARKET 30/09/2026			5-day change	1st Jan Change
0.008400 ^SEK	+2.44%		-.--%	+44.83%

10-20	Spermosens to present JUNO-Checked at fertility congress in the US	FW
08-20	Spermosens widens its loss slightly, patient recruitment beats expectations: CEO	FW

Valuation: Spermosens AB

Market Cap	26.65M 2.72M 2.43M 2.22M 2.02M 3.81M 257M 3.91M 10.66M 136M 10.22M 10M 430M	P/E 2024	-0.25x	P/E 2025	-1.6x
Enterprise Value	19.82M 2.02M 1.8M 1.65M 1.5M 2.83M 191M 2.91M 7.92M 101M 7.6M 7.43M 320M	EV / Sales 2024	-	EV / Sales 2025	-
Free-Float	-	Yield 2024 *	-	Yield 2025	-

* Estimated data More valuation ratios

Chart: Spermosens AB

NORDIC GROWTH MARKETSEK

Markets		Quality
NORDIC GROWTH MARKET	SPERM	End-of-day quote
Deutsche Boerse AG	9R5	Delayed
Börse Stuttgart	9R5	Delayed

Latest news: Spermosens AB

10-20	Spermosens to present JUNO-Checked at fertility congress in the US	FW
08-20	Spermosens widens its loss slightly, patient recruitment beats expectations: CEO	FW
08-20	Spermosens AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-06	Spermosens carries out a directed share issue of SEK 4.65m	FW
07-21	Spermosens' Board Calls SEK4.9 Million Under Capital Facility	MT
07-21	Spermosens draws SEK 4.85m from capital facility	FW
07-01	Spermosens Provides Update on Ongoing Generation 3 Clinical Study of Juno-Checked	CI
07-01	Spermosens: Recruitment is moving faster than planned, reiterates study timeline	FW
06-18	Spermosens AB Approves Board Elections	CI
05-08	Spermosens secures 4.85 million SEK financing facility	FW
05-07	Marginal bottom-line shifts for Spermosens	FW
05-07	Spermosens AB Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-07	Spermosens AB announced that it expects to receive SEK 4.85 million in funding	CI

Analysts' recommendations: Spermosens AB

02/01/25	Eyeon and Oodash 2024 winners on First North, NGM, Nordic SME and Spotlight	FW
31/12/22	ES Energy Save became this year's price rocket and Rhovac this year's worst share on Spotlight	FW

More recommendations

Press Releases: Spermosens AB

09-01	Bulletin from Extraordinary General Meeting in Spermosens AB (publ)	AQ
08-21	Spermosens: Spermosens AB (publ) to Host Live Q&A Webcast on 27 August 2026	PU
08-21	Spermosens AB (publ) to Host Live Q&A Webcast on 27 August 2026	AQ
08-20	Spermosens: Spermosens AB (publ) INTERIM REPORT APRIL – JUNE 2026	PU
08-20	Spermosens AB (publ) INTERIM REPORT APRIL - JUNE 2026	AQ

More press releases

Quotes and Performance

1 day	+2.44%
3 months	-14.29%
6 months	-28.81%
Current year	+44.83%

Price Extremes

Current year	0		0.01
1 year	0		0.01
3 years	0		0.84
5 years	0		26.2
10 years	0		26.2

Managers and Directors: Spermosens AB

Manager	Title	Age	Since
Tore Duvold CEO	Chief Executive Officer	58	01/05/2024
Alexander Dahlquist DFI	Director of Finance/CFO	55	01/01/2025
Jaime Castillo-León CTO	Chief Tech/Sci/R&D Officer	-	01/04/2025

Director	Title	Age	Since
Kushagr Punyani BRD	Director/Board Member	35	18/10/2018
Ulrik Spork CHM	Chairman	62	01/01/2024

Financials

	2024	2025
Net sales	-	-
Net income	-10.2M -1.04M -929K -849K -774K -1.46M -98.48M -1.5M -4.08M -52.15M -3.91M -3.83M -165M	-9.2M -940K -837K -766K -697K -1.31M -88.79M -1.35M -3.68M -47.02M -3.53M -3.45M -148M
Net Debt	-429K -43.81K -39.04K -35.71K -32.52K -61.3K -4.14M -62.95K -172K -2.19M -164K -161K -6.92M	-6.84M -698K -622K -569K -518K -977K -65.97M -1M -2.73M -34.94M -2.62M -2.56M -110M

Projected Income Statement - Annual - Spermosens AB

* Estimated data More financial data

Company Profile

Employees

4

Sector

-

More about the company

Stock Market
Stocks
SPERM Stock

The best tools reserved for subscribers to boost the performance of your investments!